Clinical Trial Update: To Test Bioequivalence Between Two Tablet Formulations in the Treatment of Allergy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reports a bioequivalence study between two tablet formulations for allergy, and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergy

Snippet

Sponsor: McNeil AB | Conditions: Allergy | Phase 1 | Status: COMPLETED